Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
All news
(page 11)
30 April 2026
Sinopec launches Fenghuo industrial AI agent
Introduces 'Fenghuo' industrial AI agent: a production-capable digital colleague that analyzes data, runs engineering simulations, invokes toolchains, and executes long multi-step tasks autonomously.
30 April 2026
Umicore appoints Lily Liu as CFO and Marten Zieris as Chief Digital & Transformation Officer
Outgoing CFO leaving after 20 years, advising until 28 Feb 2027. Successor has 20+ years in chemicals finance. New digital & transformation officer to lead operational excellence, digitalization and AI.
30 April 2026
TechnipFMC Q1 2026 Results
Q1 revenue $2.49B; net income $260.5M; adjusted EBITDA $466M (or $453M ex-FX); Subsea orders $1.9B; operating cash flow $332M; free cash flow $277M; $265M buyback
30 April 2026
Aptar Q1 2026 Results
Q1: sales +11% (core flat); net income -8% to $73M; EPS $1.12 (adjusted $1.19, -8% cc); adjusted EBITDA margin 2% vs 20.7%; returned $131M; Gael Touya named CEO effective Sept 1, 2026
30 April 2026
MOL to acquire O&GD upstream assets in Hungary
Buys 51% stakes in three Central Hungary concessions (~0.7 mboepd) plus Eastern Hungary assets (~0.2 mboepd), adding ~0.9 mboepd to group production; closing Q3 2026, subject to approvals.
30 April 2026
Uniper receives preliminary approval for hydrogen-ready CCGT Unit 8 at Staudinger
Regional authority grants preliminary approval for hydrogen-ready 890 MW CCGT; feasibility, emissions and habitat issues resolved; first partial permit due Q3 2026; project to enter capacity auctions
News type
Project Updates and Milestones
New Projects and Expansions
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Operational Changes and Investments
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
30 April 2026
Evonik expands Americas fast‑cure epoxy range with Ancamine 2868 and 2844
New epoxy hardeners enable rapid thin-film cure and fast property build at low temps/high humidity, boosting formulation flexibility and corrosion/carbamation resistance for protective coatings
30 April 2026
Johnson & Johnson names Ryan Koors VP, Investor Relations
Effective May 7, 2026; reports to CFO Joseph J. Wolk; succeeds Darren Snellgrove (joining Halozyme). 20+ years at the firm across Innovative Medicine, R&D, MedTech and supply chain
30 April 2026
FUCHS SE completes acquisition of OPET FUCHS JV
Completed takeover of Turkish JV, gaining full ownership of Istanbul-based entity and Aliaga (Izmir) plant. New MD Ahmet Oral from May 1. ~250 staff; ~€100M projected revenue.
30 April 2026
Avantium completes titanium weld repairs at FDCA flagship plant
Weld repairs completed with engineering partners. Commissioning continues: utilities and sugar dehydration online; oxidation and purification in final start-up. Commercial sales expected H2 2026
30 April 2026
Trinseo Q1 2026 Results
Q1 sales $725M (-8%); net loss $116M; Adjusted EBITDA $53M; Free Cash Flow -$244M; ending cash/liquidity $114M; added $50M to revolver; charges $31M
30 April 2026
Petrobras posts 1Q26 own production record of 3.23 MMboed
Ramp-up of multiple FPSOs and 10 new wells drove production gains (3.7% QoQ, 16.1% YoY); operated production 4.65 MMboed. Refining utilization, S10 diesel output and logistics records; LPG imports fell.
30 April 2026
Petrobras resumes urea production at Ansa in Araucária, PR
Urea output resumed after 2020 hibernation following R$870M reactivation; mobilization created 2,000 jobs and ~700 ongoing; restart after ARLA‑32 and ammonia tests strengthens domestic supply
30 April 2026
Elkem completes sale of Silicones division to Bluestar and redeems Bluestar shares
Registered share capital is NOK 1,505,514,210 (301,102,842 shares, NOK 5 par). Board and Nomination Committee changes took effect; seller no longer represented.
30 April 2026
Symrise expands Food & Beverage capabilities in Barcelona
Upgraded site adds powdered production and large-scale mixer, modern application and quality labs for faster prototyping, smoother scale-up, local technical support, and solar/water reuse.
30 April 2026
Umicore Q1 momentum points to ~€1bn adjusted EBITDA in 2026
Strong Q1: Catalysis and Recycling strong; Specialty led by cobalt; CAM volumes modest, take‑or‑pay compensation; anode JV in place; capex up; leverage <2x
30 April 2026
Kemira Oyj: Share repurchases, week 18/2026
Repurchased 282,380 shares (Apr 27–30) at avg €17.375, total €4,906,349.13; post-buyback treasury holdings 3,783,343 shares. Buyback part of program running until Sept 20, 2026.
30 April 2026
OMV Petrom Q1 2026 Results
Strong asset output; Clean CCS EBIT 1.5bn lei (+16%); net income 1bn lei (-4%); CAPEX 1.6bn lei (+14%); state contributions 4.1bn lei (+9%); E&P down, production -3.1%; refining margin and power output rose
30 April 2026
Borouge Q1 2026: $156M Net Profit on Operational Resilience
Q1 revenue $1.2B; production 1.21Mt (98% capacity), sales 1.09Mt. 61% of March output rerouted via alternative logistics. Prices rose 62% in March. H2 2025 dividend $658M; merger forms global polyolefins platform.
30 April 2026
BASF Q1 2026: resilient performance
Solid volume growth offset currency headwinds; EBITDA before special items €2.4bn (vs €2.5bn). Sales slightly down; free cash flow -€1.375bn. Dividend €2.25; outlook unchanged.
30 April 2026
Lhyfe to supply green hydrogen to BMW Group’s Steyr R&D centre
Multi-year deal to supply green hydrogen to an Austrian R&D site for development and validation of third-gen fuel-cell systems; first Austrian deliveries via bulk transport; RFNBO-certified.
30 April 2026
Roche to present ophthalmology portfolio data at ARVO 2026
ARVO 2026: real‑world data show Vabysmo reduces retinal fluid in nAMD/DME; Susvimo enables sustained delivery with lower treatment burden; early vamikibart IL‑6 results; 45+ abstracts.
30 April 2026
PETRONAS, ENEOS Xplora: ENEOS to re-enter MLNG Tiga with 10% stake
Reaffirmed long-term partnership strengthens energy security and steady LNG supply to Asia, notably Japan; underscores asset resilience and investor confidence in Malaysia’s LNG sector.
30 April 2026
Technip Energies Q1 2026 Results
>€6bn orders, backlog >€20bn; revenue €1.8bn, EBITDA €149m, FCF €132m (89% conv). Middle East disruptions defer €500–600m; Project Delivery guidance cut to €5.7–6.3bn; TP&S steady.
30 April 2026
Moody’s Affirms ORLEN A3 Rating
Moody's notes strong liquidity and baa2 BCA with stable outlook. Solid balance sheet and cash flows can fund capex and dividends. Diverse supply, flexible trading and 2026 projects boost resilience.
30 April 2026
Eli Lilly Q1 2026: Revenue up 56%, raises full‑year guidance
EPS jumped ~170% reported (~156% non‑GAAP); volume growth offset lower realized prices; FDA approved oral GLP‑1 Foundayo; positive Phase‑3 readouts; four acquisitions announced
30 April 2026
Merck & Co Q1 2026 Results — Sales Growth, Regulatory Approvals and Clinical Milestones
Q1 revenue $16.3B; KEYTRUDA $8.0B. GAAP loss $1.72/sh, non-GAAP loss $1.28/sh after $9.0B Cidara charge. Announced Terns acquisition; raised 2026 sales to $65.8-67.0B and non-GAAP EPS $5.04-5.16
30 April 2026
OMV: Clean CCS operating result ~EUR 1.0bn in Q1 2026
Q1: operating cash flow €776m (€1,624m excl NWC, +20%); net income €323m; leverage 17%. Energy down, Fuels flat, Chemicals up on Borealis reclass. and higher polyolefin margins; Borouge closed
30 April 2026
TotalEnergies and Nextnorth begin construction of 440 MW solar plant in Philippines
Financial close; construction begun on 440 MWp solar in Ilagan, Isabela. Online end‑2027. Produces 13.5 TWh/20 yrs; >50% sold via long‑term C&I contracts, remainder to grid via govt auction. $300M
29 April 2026
Biosimilars: stricter expectations for elastomeric closures
Originator-level assessment required (functionality, E&L, CCI). Supplier data can't replace system-level testing. Risks: format migration, dual-market filings. Adopt platform approach; decide early.
← Previous
Next →